None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Healthy men and women aged 19 years or older. 2) Individuals who have received a clear explanation of the purpose and characteristics of the study, agreed to participate, and signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1) Individuals with moderate to severe heart disease or hypertension stage 2 or higher. 2) Individuals experiencing chest pain at rest, during daily activities, or while engaging in physical activity. 3) Individuals who have fainted or lost consciousness due to dizziness within the past six months. 4) Individuals with current (or within the past six months) musculoskeletal issues (bones, joints, or soft tissues such as muscles, ligaments, or tendons) that may worsen with increased exercise. 5) Individuals with skin diseases or open wounds at the measurement site. 6) Individuals who have difficulty communicating and have limitations in reading or completing questionnaires. 7) Individuals who have engaged in sweating-inducing exercise or strength training within 24 hours prior to the electromyography (EMG) measurement experiment. 8) Individuals with a history of psychotic disorders, alcohol addiction, or substance abuse. 9) Any other individuals deemed inappropriate for participation in the clinical trial by the research investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| EMG (MVIC%) | — |
Countries
Korea, Republic of
Contacts
Wonkwang University. Iksan Korean Medicine Hospital